Virios Therapeutics, Inc.
Virios Therapeutics, Inc. (VIRI) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 29 transactions totaling $609.4K, demonstrating a bullish sentiment with $608.5K in net insider flow. The most recent transaction on Aug 21, 2023 involved a purchase of 15,335 shares valued at $19.9K.
VIRI Insider Activity Summary
Who Is Buying VIRI Stock?
No significant insider buying has been recorded for VIRI in the recent period.
Who Is Selling VIRI Stock?
No significant insider selling has been recorded for VIRI in the recent period.
Is Virios Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VIRI is bullish with an Insider Alignment Score of 100/100 and a net flow of $608.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VIRI Frequently Asked Questions
Understanding VIRI Insider Activity
Insider trading at Virios Therapeutics, Inc. (VIRI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading VIRI stock, having executed 29 transactions in the past 90 days. The most active insider is Gregory Scott Duncan (Executive), who has made 7 transactions totaling $294.9K.
Related Tools
Track Virios Therapeutics, Inc. Insider Activity
Get notified when executives and directors at VIRI file new Form 4 transactions